We studied papillary muscle mechanics and energetics, myosin phenotype, and ATPase activities in left ventricles from rats bearing a growth hormone (GH)-secreting tumor. 18 wk after tumor induction, animals exhibited a dramatic increase in body weight (+101% vs. controls) but no change in the ventricular weight/body weight ratio. The maximum isometric force of papillary muscles normalized per cross-sectional area rose markedly (+42%, P < 0.05 vs. controls), whereas the maximum unloaded shortening velocity did not change. This was observed despite a marked isomyosin shift towards V3 (32±5% vs. 8±2% in controls, P < 0.001). Increased curvature of the force-velocity relationship (+64%, P < 0.05 vs. controls) indicated that the muscles contracted more economically, suggesting the involvement of V3 myosin. Total calcium-and actinactivated myosin ATPase activities assayed on quickly frozen left ventricular sections were similar in tumor-bearing rats and in controls. After alkaline preincubation, these activities only decreased in tumor-bearing rats, demonstrating that V3 enzymatic sites were involved in total ATPase activity. These data demonstrate that chronic GH hypersecretion in the rat leads to a unique pattern of myocardial adaptation which allows the muscle to improve its contractile performance and economy simultaneously, thanks to myosin phenoconversion and an increase in the number of active enzymatic sites. (J. Clin. Invest.
Introduction
In humans, chronic hypersecretion of growth hormone (GH)' is usually due to a pituitary adenoma and is responsible for acromegaly. Chronic hypersecretion of GH, and of somatomedin C (also called IGF-I), which mediates most of the biological effects of GH, has many morphological, functional, and metabolic consequences (1) . Cardiovascular alterations consisting of cardiomegaly and hyperkinetic heart syndrome are almost always present (2) (3) (4) (5) (6) (7) . In many patients, heart failure occurs, and cardiovascular diseases are a major cause of death (8) . Although diabetes mellitus, systemic hypertension, and coronary heart disease are especially frequent during acromegaly, alterations in cardiac function in acromegalic patients free of all these pathological conditions have suggested the existence of a cardiomyopathy specific for acromegaly (9) (10) (11) (12) (13) (14) .
Little is known about the pathophysiology of any such cardiomyopathy (2, 5, 6, 9) . Cardiac hypertrophy has been observed in rats bearing GH-secreting transplantable tumors (15) or repeatedly treated by GH injections (16) . In hemodynamic studies, conflicting observations have been reported consisting either of a hyperkinetic heart syndrome with increased cardiac output and positive derivative of the left ventricular pressure (+dP/dt) and reduced systemic vascular resistance (15) , or depressed indices ofcardiac pump function with reduced +dP/dt (17) . Furthermore, these changes are indices of altered pump function of the heart, and are highly dependent upon its loading conditions, which change markedly during chronic GH hypersecretion (7, 15) . Finally, nothing is known at present about the intrinsic contractile properties of the myocardium during this pathological condition.
Intrinsic contractility of the myocardium is defined by a whole spectrum of parameters measured on isolated muscle. One of the most important is the maximum shortening velocity of the unloaded muscle (Vm.), because it has been shown to be related to the nature of the constituent myosin, the main protein of the sarcomere's thick filament (18). In a variety of skeletal and cardiac muscles, positive linear relationships have in fact been observed between the ability ofmyosin to catalyze adenosine triphosphate hydrolysis (i.e., ATPase activity), the reaction which furnishes the energy necessary for contraction, and the Vma,, of the corresponding muscles (19, 20) . Myosin consists of a pair of heavy chains (MHC), which contain the hydrolytic enzymatic site, and two pairs of light chains, the modulatory role of which has not yet been completely established in the myocardium (18, 21) . In the mammalian heart, two forms of MHC (a and 13) are encoded by separate genes (22) . They combine to give rise to three isomyosins consisting oftwo homodimers, VI (a, a) and V3 (13, ,B) with high and low ATPase activity, respectively, and one heterodimer V2 (a, 13) with intermediate activity (23) (24) (25) . All three can be easily distinguished by their electrophoretical mobility (26, 27) . Under various physiological and pathological conditions, including development (24) and hormonal (26, 28) and chronic hemodynamic alterations (25, (29) (30) (31) , the relative proportions of these isomyosins change as a result of modifications in the expression of the corresponding genes (32, 33) . These changes are well correlated with the alterations in the myocardial performance of the different rat and rabbit models so far studied (34) (35) (36) (37) (38) .
Using the same left ventricular papillary muscles from rats chronically exposed to GH hypersecretion, we studied both the intrinsic contractility and the relative proportions of the three isomyosins. We also measured the calcium-and actin-activated myosin ATPase activities in cryostatic sections of quickly frozen left ventricles from a similar group of rats. This was done because myosin ATPase activities measured in this way are more likely to reflect the in vivo function of the active enzymatic sites modulated by their regulatory systems than methods using isolated myofibrills or purified proteins (21, 39) . Our results show that chronic GH hypersecretion was associated with an increase in papillary muscle active force normalized per cross-sectional area and no change in both the unloaded shortening velocity of the isolated muscles and the calcium-and actin-activated myosin ATPase activities. This contrasted strongly with a marked shift of the isomyosin pattern towards the low ATPase activity V3 isoform.
Methods
Rat model of chronic GH hypersecretion. Care of the animals and conduct of all experiments were in accordance with the recommendations of the Helsinki Guidelines. GC cells were cultured in Ham's FlO medium supplemented with 15% horse serum and 2.5% fetal calf serum (Gibco-BRL, Cergy-Pontoise, France). A suspension of 10-15 X 106 cells in Hanks' medium (0.3 ml vol) was injected subcutaneously into the flank of 10-12-wk-old female Wistar Furth rats (Iffa Credo, L'Arbresle, France) under sodium metohexitone anesthesia (40 mg/kg i.p.). Animals were weighed weekly. Tumor-bearing rats were divided into three groups. Group Al (n = 5) was studied 10 wk after injection, and group A2 (n = 4) 18 wk after injection. In group A3 (n = 4), the tumor was resected under anesthesia 10 wk after injection and the animals were studied 8 wk later (i.e., 18 wk after injection). Corresponding groups of control littermates (n = 6, 5, and 5, respectively), were also studied.
Rats were anesthetized i.p. with 30 mg/kg sodium pentobarbital, weighed, and killed. Blood was collected through the inferior vena cava. The heart was quickly removed and the two left ventricular papillary muscles were carefully excised for the mechanical study. The heart was washed in ice-cold saline and dissected free of the atria.
Ventricles were weighed and frozen immediately in liquid nitrogen, and the two papillary muscles were also frozen at the end of the mechanical study in order to determine their isomyosin patterns. Blood was centrifuged and plasma was frozen for hormonal assays.
A fourth group oftumor-bearing rats (A4, n = 5) and their controls (n = 4) were used to study calcium-and actin-activated myosin ATPase activities in sections ofthe left ventricle. 18 wk after injection ofthe cell suspension, they were killed by decapitation. In < 1 min the heart was excised and washed, the right ventricle was removed, and the left ventricle was frozen in isopentane previously cooled in liquid nitrogen (39).
Hormonal assays. Plasma GH and prolactin concentrations were determined by radioimmunoassay (RIA) using reagents provided by the National Institute of Arthritis, Digestive Diseases, and Kidney as described (40) . The free fraction of triiodothyronine (FT3) was measured using a commercially available kit (FT3-RIAsol, Henning, GmbH, Berlin, FRG). All determinations were done in duplicate.
Papillary muscle mechanics. < 1 min after rats were killed, left ventricular papillary muscles were suspended vertically in a 60-ml Krebs-Henseleit bicarbonate buffer solution containing CaCI26H2O 2.5 mM, pH 7.40 (41) . Temperature was maintained at +290C. Muscles were field-stimulated at 0.12 Hz by means of two platinum electrodes with rectangular wave pulses of 5-ms duration and amplitude just above threshold. The electromagnetic level system has already been described (41) . The system had a linear range up to 2.5 mm of muscle shortening (resolution < 0.1 mm). The amplitude of the force ranged from 0 to 100 mN (resolution <0.1 ImN). The equivalent moving mass ofthe whole system was 155 mg, and the compliance was 0.2 gm/mN. After a 1-h stabilization period at L. (i.e., the initial muscle length corresponding to the apex ofthe length-active isometric tension relationship), papillary muscles had recovered their optimal mechanical performance. All analyses were made from digital records obtained with a computer (model 1000, Hewlett-Packard Co., Palo Alto, CA). (1) where M2 is the normalized peak power output. The product a X b has been found to represent the rate of maintenance heat production (43, 45) . From a thermoenergetic point of view, G, the curvature of the force-velocity relationship has been proposed to reflect the efficiency of muscle contraction (37, 44, 46) . The higher the G value, the higher the myothermal economy of contraction.
Isomyosin pattern. The isomyosin pattern was determined for each papillary muscle, and for the epicardial half of the left ventricular free walls of the rats in group A4, as previously described (30 Female Wistar-Furth rats were studied 10 wk (Al), and 18 wk (A2) after subcutaneous injection of GH-secreting GC cells. In group A3, tumors were allowed to grow for 10 wk and were then resected. Rats were studied after an 8-wk recovery period. GH and FT3 were measured by RIA.
Results are means±SD. C, control. * P < 0.05 vs. C; *P < 0.05 vs. A2; § P < 0.05 vs. Al.
ATPase activities were measured by quantitative microphotometry as previously described (39, 47) . The principle of the method consists of trapping the inorganic phosphate produced by ATPase activity with calcium ions, and the quantitative replacement of the calcium phosphate by the more opaque cobalt sulfide. The optical density (OD) in each of 10 alternate serial sections of each left ventricle was measured on a digitized image, using a TV camera attached to a photomicroscope (Carl Zeiss, Inc., Oberkuchen, FRG). The calcium-or actin-activated myosin ATPase activity of each left ventricle is proportional to the mean OD values measured in each ofthe 10 sections. The standard error was < 2%. In each experiment, the left ventricles of a tumorbearing and of a control animal were studied. The calcium-and actinactivated myosin ATPase activities were measured in the presence of ouabain and azide to inhibit the Na+/K+-and mitochondrial ATPases, respectively. Myosin ATPase activities were assayed both after preincubation at neutral pH, which allows the determination of the total ATPase activity, and after inhibition of the V3 isomyosin by preincubation at alkaline pH (10.3) in the absence of ATP, which permits the measurement of the ATPase activity due to VI only (23, 39, 47).
Relative ATPase activities are indicated by absorbance units. The myosin phenotype was determined in the subepicardium of the left ventricles, exactly where the sections had been cut.
Statistical analysis. Data were expressed as means±SD. Control groups were compared by one-way analysis of variance. As no differences in mechanical, biochemical or hormonal parameters were observed, the control groups (16 rats, 31 papillary muscles) were pooled. Groups C, Al, A2, and A3 were compared by one-way analysis of variance and Student's t test with the Bonferroni correction. For the myosin ATPase activity study, paired and unpaired Student's t tests were used as appropriate. All comparisons were two-tailed and a P values < 0.05 were considered significant.
Results
Effects oftumor growth on rat body weight (BW), ventricular weight (VW), and plasma hormone levels. Tumor growth occurred in 90% of injected rats. BW increased as a function of time in the rats of groups Al and A2, whereas it plateaued at about 220 g in the controls (Table I) . In group A3, rat BW increased similarly during the first 10 wk postinjection up to 424±14 g, but dropped sharply to 333±19 g soon after tumorectomy. However, at 18 wk, the BW ofthese animals remained higher than that of their age-matched controls (324±14 vs. 216±6 g, P < 0.001). VW was also greater in the three groups of tumor-bearing animals than in controls but the VW/BW and left VW/BW ratios were not different from control ratios ( Table I ), indicating that no cardiac hypertrophy (i.e., no increase in the heart weight to BW ratio) occurred in tumorbearing rats. Left ventricular papillary muscles were longer in the rats of groups Al and A2 than in the controls, but the cross-sectional area was significantly larger in group Al only (Table II) . As expected, GH plasma levels were dramatically higher in tumor-bearing rats than in controls, and about twice as high in group A2 as in group Al. By contrast, in group A3, GH plasma levels were normal 8 wk after tumorectomy (Table   I ). The plasma FT3 concentration was not different in groups Al and A3 from that of the controls, but was lower in group A2. Prolactin plasma concentration did not increase in any of the three injected groups of rats compared to their controls (data not shown).
Papillary muscle mechanics. Fig. 1 shows characteristic traces of force and shortening as a function of time in a papillary muscle contracting against various loads from a control and a tumor-bearing rat in group A2. The main mechanical parameters derived from these traces are indicated in Table III. The maximum shortening velocity of the unloaded muscle (V.,), did not differ from control values in any experimental group of rats. By contrast, the active force normalized per cross-sectional area (AFIs), which was already increased, but not significantly, in group Al compared to the controls, rose markedly in group A2 (Fig. 2 and Table III Papillary muscle energetics. The parameters which account for the energetics of papillary muscles contraction are given in Table IV . G, the curvature of the force-velocity relationship progressively increased in groups Al and A2 vs. the controls. This increase did not reach statistical significance in group Al, but was dramatic in group A2 (+64%, P < 0.05 vs. controls). This increase suggested that papillary muscles of tumor-bearing rats contracted more economically than control muscles. As a consequence of the increase in G, M2, the normalized peak power output, decreased in tumor-bearing rats. In group A2, this decrease was 16% of the control value (P < 0.05). It was interesting to observe that the peak power output rmax did not change in any group oftumor-bearing rats. This can be explained by the decrease in M2 which roughly compensated the increase in TFmax/s, whereas Vmax did not change (see Eq. 1 in Methods). In the A2 group, only the b coefficient decreased significantly. This decrease, combined with an unsignificant decrease in the a coefficient, resulted in a decrease of about 50% in the calculated isometric maintenance heat rate (a X b) (P < 0.05 vs. controls). In group A3, the alterations observed in muscle energetics in group A2 were prevented by tumor resection.
Isomyosin pattern ofpapillary muscles. Typical gels of a papillary muscle from each ofthe four groups of rats are shown in Fig. 3 . The relative proportions of V 1, V2, and V3 isomyosins are shown in Fig. 4 . In control rats, V1 was the predominant isoform (64±3% of total myosin) and V3 was only 8±2%.
Together with V2, this corresponded to 22±2% f3-MHCs. A decrease in V 1 (54+2%, P < 0.01 vs. controls) was observed in muscles from group Al rats and a parallel increase in V3 ( 19±2%, P < 0.01 vs. controls). A dramatic shift was observed in A2 rats in which VI dropped to 34±5% and V3 rose to 32±5% (P < 0.001 vs. controls for all comparisons). Together with V2, this corresponded to 49±5% fl-MHCs. Consequently A2 rats had 27% more j3-MHCs than controls. In A3 rats, the proportions ofeach isoform were very similar to those ofgroup Al (50±4% and 18±3% for Vl and V3, respectively, NS vs. group Al for all comparisons). Thus, tumorectomy at 10 wk, which was associated with a large, fast drop in BW and with normalization of GH plasma levels, was not associated with normalization of the isomyosin pattern, but rather prevented the shift observed in the animals bearing the tumor for 18 wk.
In group A4, a marked isomyosin shift was observed as in the other tumor-bearing rats (Table V) . Indeed, in the subepicardium, V3 constituted 16±4% of total myosin, whereas no V3 was detected in that of control rats. These percentages were lower than those measured in the papillary muscles of tumorbearing rats and their controls. This could be explained by the regional variations in ventricular isomyosin distribution previously reported (31, 48) . Together with 35+4% V2, the 16±4% V3 in the subepicardium of group A4 rats yielded 33% j3-MHCs compared with 0% in their controls (Table V) . This difference in the percentage of f-MHC was approximately the same as that observed between the papillary muscles of rats in group A2 and their controls (27%).
Calcium-and actin-activated myosin A TPase activities.
Most interestingly, despite the profound isomyosin shift observed in the subepicardium of the left ventricles in group A4 rats compared with controls, both calcium-and actin-activated myosin ATPase activities at neutral preincubation were almost exactly identical in the two groups of rats (Table V) 
Discussion
Our study is the first to assess the intrinsic contractile properties of the myocardium in rats subjected to chronic GH hyper- secretion, and to determine the myosin phenotype in the same left ventricular papillary muscles, the necessary condition for rigorous examination of the relationships between the mechanical and biochemical parameters of muscle contraction. Furthermore, in another group of rats, we measured the calcium-and actin-activated myosin ATPase activities and the corresponding isomyosin pattern in the left ventricular free wall. The results clearly show that in tumor-bearing animals, normal or supranormal myocardial contractility was associated with normal myosin ATPase activities, despite a marked phenoconversion of myosin toward V3. Thus, our separate mechanical and enzymatic studies consistently demonstrated that chronic GH hypersecretion in rats induced a unique pattern of myocardial contraction: a normal shortening speed and an increased force generation are associated with changes in myosin phenotype that allow the muscle to function more economically.
The existence of alterations in cardiac function in human subjects submitted to chronic GH hypersecretion has been known for a long time (8) . In most patients with acromegaly, cardiac hypertrophy is present and is associated with an hyperkinetic heart syndrome (3, 7). In both GH-deficient patients (50, 5 1) and normal volunteers (52) , treatment with recombinant GH has been suggested to increase myocardial performance and cardiac output. Conversely, in acromegalic patients, treatment with octreotide, the somatostatin analogue, reduced left ventricular mass and echographic indices of myocardial contractility (53) . Few . Mean percentage of each myosin form in left ventricular papillary muscles from control rats (C, n = 13), and from GH-secreting tumor-bearing rats in groups Al (n = 9), A2 (n = 8), and A3 (n = 7). Bars represent SD. P < 0.01 for comparisons of VI% and V3% in groups Al, A2, and A3 vs. C, in group A2 vs. Al, and in group A3 vs. A2; NS for the same comparisons of A3 vs. Al. function in experimental models of chronic GH hypersecretion. In the most documented hemodynamic study in the rat, the alterations reported were clearly consistent with the hyperkinetic heart syndrome observed in man; thus, increases in cardiac index, +dP/dt max, and aortic blood flow were combined with normal arterial pressure and a decrease in systemic vascular resistance (15) . Since hemodynamic studies give little direct information about the intrinsic contractile properties of the myocardium, our goal has been to assess the various mechanical and biochemical parameters which characterize myocardial contractile function in this peculiar model of cardiac growth. We used the model of the tumor derived from GC cells which secretes large amounts of biologically active GH, as demonstrated by plasma GH levels, which were 50-100 times higher in tumor-bearing rats than in controls, and by the marked overgrowth of these animals. A number of procedures resulting in a chronic increase in plasma GH have been described in small mammals, including daily GH injection (16), implantation of tumors secreting GH and prolactin (15, 54) , and transfection of mice oocytes with the GH or GH-releasing hormone gene (55, 56) . Our model offers several advantages: it is easily produced and the removal of the subcutaneous tumor allows study ofthe response to termination of GH hypersecretion at different stages. In addition, the absence of excessive secretion of prolactin by the GC cell-derived tumor eliminates the many known effects of this hormone, particularly on the water and sodium balance (57) .
We did not observe any cardiac hypertrophy in the rats exposed to chronic excess of GH. Although we observed considerable enlargement of both ventricles in the three groups compared with the controls, neither the VW/BW ratio nor the ratio of each ventricle's weight to body weight altered. In a previous study of rats bearing the MtT-W-15 GH-secreting tumor (15), a 33% increase in the VW/BW ratio was observed in rats with "large" tumors compared to the controls, essentially to the benefit of the right ventricle. The reason for this discrepancy is not clear, since in both studies the duration and level of GH hypersecretion were essentially the same. By contrast our results are in full agreement with the study by Gilbert et al. (54) , who used a model close to ours. They found a normal VW/BW ratio in tumor-bearing rats, although the plasma GH levels they measured were even higher than those observed here. In detailed pathological studies carried out by the same group, the hearts only exhibited an increase in myocyte length (58) . These and our results therefore seem to indicate that chronic GH hypersecretion in rat is associated with a growth ofthe heart proportional to the growth ofthe body. We also observed that tumor-bearing rats had both normal Vm,, and increased AF/s. This is in sharp contrast with what occurs in all models of chronic hemodynamic overload which result in ventricular hypertrophy, associated with a decrease in Vma.
and AFIs (34, 35, 37, 38, 46) .
The most striking finding in our study was the observation that normal or supra-normal contractile performance in tumor-bearing rats was associated with a marked isomyosin shift towards V3. To our knowledge, this is the first demonstration in the adult rat of a dissociation between myocardial myosin phenotype and contractility. Chronic hemodynamic overload, aging, and hypothyroidism are associated with a decreased Vm. and an increased proportion of V3, whereas the opposite is seen in young animals and in hyperthyroid or old animals treated by thyroid hormone. Strong linear correlations were found between the proportions of each one of the two main myosin isoforms and Vma,, in rats exhibiting these various physiological and pathological conditions (18, 34, (36) (37) (38) . According to these correlations, the 34% VI and 32% V3 that we measured in the papillary muscles of the rats in group A2 compared with the 64% VI and 8% V3 in the controls should have been associated in tumor-bearing rats, with a decrease of Vma. ofat least 30%, which we did not in fact observe. It is also worthwhile to note that during chronic hemodynamic overload in which myosin phenoconversion towards V3 is observed, AFIs is decreased in contrast to the marked increase observed here (34, 37, 38) . Myosin phenoconversion we observed in group A2 rats might be explained in part by the lower FT3 plasma concentration noted in these rats. However, a significant shift towards V3 also occurred in the animals ofgroup Al, which had normal FT3. These data are fully consistent with the results reported for rats injected with GH for 5 wk, whose Vl in the left ventricle decreased by 25% while their plasma T3 levels were normal (16) . Moreover, hypothyroidism is associated with a great reduction in Vma. (34, 35) and AFIs (34, 49) , which we did not observe in our model.
One of the important points in this study is the consistency between the results of the mechanical, energetical and enzymatic studies. Moreover, the relations that can be established between several of the measurements performed bring some insight into the alterations which have occurred in the mechanisms of myocardial contraction of tumor-bearing rats. It is generally agreed in the isometric twitch, that the maximum active force is a function of the number of active cross-bridges (44, 45, 59, 60) . In our study, the 42% increase in AFIs in group A2 (Table III) , indicates an increase in the number of active cross-bridges. The results of the enzymatic study support this conclusion. Since V3 has an ATPase activity 0.3 of Vl (23, 24, 49) , the constant total ATPase activity in tumorbearing rats despite the contribution by V3 (assessed by the appearance of sizable alkaline labile ATPase activity), shows that a larger number of cross-bridges were active, -50% by calculation from the actin-activated myosin ATPase activities of rats in group A4 (Table V) . A similar conclusion can be drawn from analyzing the data within the framework of the "two state" model of cross-bridges (45, 60) . In this model, force of the isometric twitch and myosin ATPase activity are both defined as functions of the number of cycling crossbridges and of the rate constants of the transition to the forcegenerating state (f) and of the return to the non-force-generating state (gl and g2). According to this model, force per ATP split is inversely proportional to gl. In our study, the increase in isometric force together with the unchanged myosin ATPase activity in tumor-bearing rats, indicates a decrease in gl which in the presence of this unchanged ATPase activity suggests an increase in the number of cycling cross-bridges. The constancy of both Vm. and total myosin ATPase activity in tumor bearing rats agrees well with the close relationship established between these two parameters in the various cardiac and skeletal muscles (19, 20) . Since, in A. F. Huxley's model, Vmax depends directly upon the g2 rate constant of the exit from the force-generating step, our results suggest that this rate constant was unchanged in tumor-bearing rats.
Despite increased intrinsic myocardial performance, the myosin phenoconversion in tumor-bearing rats was associated with increased economy of force generation (Fig. 2) . In fact, the G curvature of the force-velocity relationship is related to the kinetics of myosin cross-bridges (44, 45) . Fast twitch skeletal muscles and cardiac muscles containing high proportions of V 1 exhibit a low G curvature, whereas the opposite is true for slow twitch skeletal muscles and cardiac muscles with a high proportion of V3 (37, 44, 46) . It has been clearly demonstrated that the latter muscles develop force more economically than the former muscles (37, 44, 46, 49) . In our study, the increase in the G curvature is in full agreement with the biochemical demonstration of the presence of functional V3 enzymatic sites. In the context of the A. F. Huxley model, in which the G curvature is a function of the rate constants of cross-bridges cycle, the observed increase in the G curvature could be predicted from the above mentioned alterations in these rate constants.
The radical changes in myocardial myosin phenotype, mechanics and energetics demonstrated here in rats submitted to chronic GH hypersecretion may be due to several factors, including alterations in the working conditions of the heart and/ or direct effects ofGH or IGF-I on cardiac myocytes. Although we cannot preclude that a tumor product other than GH (or IGF-I) could be responsible for these changes, this is very unlikely if one consider the effects described by investigators using other GH-secreting cell lines (15, 61) or injections of recombinant GH (16) . Moreover, we found significant correlations in tumor-bearing rats between plasma GH and BW, heart weight, percentages of VI and V3 in the papillary muscles (data not shown). Little is known about a putative direct effect of GH (or IGF-I) on the myocardium. One can simply note that GH administration in rats is associated with an increase in the myocardial concentration of IGF-I and its mRNA (62, 63) . Binding sites for IGF-I have also been de-tected in neonatal rat myocardium (64) . In addition, in humans treatment with recombinant GH enhances myosin heavy chain mRNA accumulation in skeletal muscle (65) .
In conclusion, our mechanical and enzymatic studies consistently showed that during chronic GH hypersecretion, the recruitment of an increased number of functionally active enzymatic sites is responsible for normal overall ATPase activities, normal Vma., and increased force development per muscle cross-sectional area. In addition, both the increased G curvature of the force-velocity relationship and the presence of functionally active V3 enzymatic sites strongly suggested that despite the increase in contractile performance, the myocardium functioned at a lower energetic cost. To our knowledge, chronic GH hypersecretion is thus the only case demonstrated to date in which, despite increased force generation, a normal shortening speed and peak power output, changes in the myosin phenotype allow the muscle to function more economically. This situation contrasts with the one created by chronic hemodynamic overload, in which cardiac hypertrophy, myosin phenoconversion and increased economy of force generation are associated with decreased Vm., AFIs, and .E. From a thermoenergetic point of view, chronic GH hypersecretion therefore induces a new pattern of adaptation of the myocardium which might help the heart pump to increase its performance with a better efficiency.
